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Cortical actinThe actin cytoskeleton is substantially modiﬁed in cancer cells because of changes in actin-binding protein
abundance and functional activity. As a consequence, cancer cells have distinctive motility and mechanical
properties, which are important for many processes, including invasion and metastasis. Here, we studied the
effects of actin cytoskeleton alterations induced by speciﬁc nucleation inhibitors (SMIFH2, CK-666), cytochalasin
D, Y-27632 and detachment from the surface by trypsinization on themechanical properties of normal Vero and
prostate cancer cell line DU145. The Young's modulus of Vero cells was 1300 ± 900 Pa, while the prostate
cancer cell line DU145 exhibited signiﬁcantly lower Young's moduli (600 ± 400 Pa). The Young's moduli
exhibited a log-normal distribution for both cell lines. Unlike normal cells, cancer cells demonstrated diverse
viscoelastic behavior and different responses to actin cytoskeleton reorganization. They were more resistant to
speciﬁc formin-dependent nucleation inhibition, and reinforced their cortical actin after detachment from the
substrate. This article is part of a Special Issue entitled: Mechanobiology.
© 2015 Elsevier B.V. All rights reserved.1. Introduction
One of the major characteristics of cancer cells is their ability to mi-
grate to nearby tissues, blood or lymph vessels and to form secondary
tumors at multiple distant sites. Tumor metastases are responsible for
approximately 90% of all cancer-related deaths [1]. The mechanism by
which malignant cells develop such ability involves changes in their
mechanical properties and actin cytoskeleton dynamics. The ability to
move is a basic property of living cells. The movement of cells and cell
layers organizes and determines the formation of organs in embryogen-
esis, wound healing and the progress of inﬂammation. The actin cyto-
skeleton, together with other factors (nucleation promoting factors,
microtubules, intermediate ﬁlaments, lipids), is responsible for these
functions [2]. The dynamics of the cytoskeleton are regulated by actin-
binding proteins (ABPs) promoting actin turnover, the key process
in cellular motility [3]. The Arp2/3 complex is responsible for actin
branching [4]. Coﬁlin and the Srv2 complex coordinate actin cable
severing [5] and actin depolymerization [6,7]. Formin family proteins
regulate the polarized growth of cells, stress ﬁber formation, and actin
nucleation [8–10]. They also coordinate interactions between actin ﬁla-
ments and microtubules [11]. Cytoplasmic formins are autoinhibitedobiology.
w State University, Faculty of
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).[12] and activated upon interactionwith Rho GTPases [13]. After activa-
tion, they processively nucleate long actin cables, thus generating lead-
ing edge protrusions [14]. Recently, a signiﬁcant increase of formin
expression in colorectal cancer [15–17] and leukemia [18] has been
demonstrated. It has been hypothesized that formins may act as
tumor suppressors [19], yet no such activity has been speciﬁcally
identiﬁed.
Nucleation of the actin branch by the Arp2/3 complex occurs in
combination with other proteins including the N-WASP/WAVE family.
The activated complex binds to the side of the existing ﬁlament, aligns
in a similar manner to an actin dimer and nucleates the formation of
a new ﬁlament, which extends from the side of the existingﬁlament at a
70° angle. Dense branched networks generated by Arp2/3 activity are
essential for mesenchymal invasion and the formation of lamellipodia
and invadopodia. Overexpression of WASP family proteins and the
Arp2/3 complex has been associated with malignant phenotypes of
several human cancers, including breast [20], colorectal [21], lung [22],
and head and neck squamous cell carcinoma [23].
In cancer cells, the actin cytoskeleton is substantially modiﬁed,
accompanied by changes in the expression and activity of ABPs [19,24,
25]. As a result, cancer cells have distinctive mechanical properties
from both normal and benign cells. With some exceptions [26–28], a
low rigidity of cancer cells was reported in the majority of works
[29–35]. It has been suggested that the elastic properties of cancer
cells play a major role in the metastatic process, and the degree of
deformability of cells has been proposed as a marker for metastatic po-
tential [36,37]. Hypothetically, more aggressive cancer cells should
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undergo substantial mechanical deformation during tissue invasion,
intra- and extravasation. Yet results from recent studies show all
possible types of correlation (direct, reversed, nonsigniﬁcant, and com-
plicated) between the cell stiffness and the metastatic potential of can-
cer cells [30,34,35,38–40], meaning that the independent mechanical
characterization is not sufﬁcient to evaluate the metastatic potential of
cells. Further investigations related to mechanical aspects, such as
measurements in different conditions and after different treatments,
are required to understand the connection of mechanical compliance
with the metastatic potential.
Recently, several methods were suggested to characterize the me-
chanical properties of cells including different types of microrheology
[41], optical tweezers [42], micropipette aspiration [43], magnetic
tweezing cytometry [44], atomic force microscopy (AFM) [37,45,46]
and others. Previously, we employed force spectroscopy, a commonly
used AFM technique, to investigate the elastic properties of non-
transformed epithelial Vero cells and showed that this cell line may be
a good experimental model for studying the effects of different treat-
ments on cell mechanical properties [47]. Here, we examined the
mechanical properties (quasi-static and complex Young's moduli) of
prostate cancer cells DU145, and compared them to normal Vero cells
before and after different actin cytoskeleton reorganizations. Although
the studied cell lines have different origins (both are epithelial, but
Vero are from monkey healthy kidney and DU145 are from human
prostate cancer), we showed here that they share some common prop-
erties with normal (Vero) and malignant (DU145) cells, which include
cytoskeleton structure, migration abilities and mechanical parameters.
The effects of inhibitors of the major actin nucleators, formin and
Arp2/3, Cytochalasin D (CytD) and Y-27632 (ROCK inhibitor) treat-
ments, as well as the detachment of cells from the culture substrate
by trypsinization, were studied.
2. Materials and methods
2.1. Cell cultivation
Human prostate cancer epithelial cell line DU145 with medium
invasiveness was chosen for the experiments [48]. A healthy African
green monkey Cercopitecus aethiops kidney cell line (Vero) served as a
control. Both cell lines were grown in DMEM (PanEco, Russia) with
10% fetal bovine serum (FBS) (HyClone, USA). Cells were grown at
37 °C in a humidiﬁed 5% CO2 atmosphere in a CO2-incubator (Sanyo,
Japan) for 5–6 passages after being defrosted. For AFM imaging and
force spectroscopy, cells were harvested from subculture, seeded on
sterile glass coverslips (Menzel-Gläser, Germany) in sterile 35 mm
Petri dishes and placed into the incubator at the same conditions as
stated above for 1–2 days.
The cells were treated with the following compounds: SMIFH2 – an
inhibitor of formin-mediated actin assembly [49]; CK-666 – an inhibitor
of the Arp2/3 complex-dependent pathway of actin nucleation [50];
Cytochalasin D (all from Sigma-Aldrich, Germany) – an inhibitor of
total actin polymerization; and Y-27632 (Abcam, UK) – inhibitor of
the Rho kinase (ROCK) pathway of myosin light chain phosphorylation.
Stock solutionswere prepared in DMSO, and then reagentswere diluted
to ﬁnal concentrations in a serum-free medium. Trypsinization was
performed by the replacement of the cell culture medium with 0.25%
Trypsin–EDTA in HBSS (PanEco, Russia).
2.2. Confocal microscopy
For confocal ﬂuorescence imaging, cells were seeded on sterile
35 mm glass bottom Petri dishes (Greiner Bio-one, Germany) at a den-
sity of 3 * 105 cells per dish and allowed to grow for the next 24 h. Then,
the cells were ﬁxed with 2% formaldehyde, permeabilized with 0.4%
Triton-X100 in PBS, and stained. The ﬁlamentous actin (F-actin) waslabeled with ﬂuorescent phalloidin conjugate (with Alexa Fluor® 488
or Alexa Fluor®546, Life Technologies, Europe). Cell nucleiwere stained
with DAPI (Life Technologies, Europe). The samples weremounted into
the SlowFade® medium (Life Technologies, Europe). Fluorescence
images were taken using Zeiss LSM510 Meta or Zeiss LSM710 Meta
inverted confocal microscopes (Carl Zeiss, Germany) with a 63 × α
(alpha)-Plan-Apochromat oil-immersion objective (NA = 1.46, Carl
Zeiss AG).
For quantitative F-actinmeasurements after different treatments the
staining procedure was slightly modiﬁed from the above. Control and
treated cells were cultivated separately on the same glass slide
(Menzel-Gläser, Germany) with attached Flexiperm silicone wells
(Greiner Bio-one, Germany). After removing the silicone wells, the
cells were ﬁxed and stained in an identical way on the same slide, so
the direct comparison of relative amounts of F-actin was possible.
Fluorescence of Alexa Fluor® 546 phalloidin and DAPI were recorded
using a Z-stack regime. The Image J software (National Institutes of
Health, USA) was used for processing the ﬂuorescent images. At least
40–50 cells were examined in each sample. The quantitative map of
the Alexa Fluor® 546 phalloidin distribution was calculated for each
measured cell and processed with the Image J software to estimate
average cytoplasmic ﬂuorescence intensity.
2.3. In vitro Matrigel invasion assay
Cell invasion experiments were performed using Bio-Coat cell
migration chambers (BD Biosciences, USA) according to the
manufacturer's protocol. Insertswere composed of 8 μmpore size ﬁlters
coated with the Matrigel basement membrane matrix (BD Biosciences,
USA). Brieﬂy, detached cells (2 * 105 in 500 μl of serum-free DMEM/
RPMI medium) were added to each insert (upper chamber), and the
chemoattractant (5% FBS in DMEM/RPMI) was placed in each well of a
24-well companion plate (lower chamber). After 14-h incubation at
37 °C in a 5% CO2-incubator, the noninvasive cells from the upper sur-
face of the ﬁlter were thoroughly removedwith a cotton swab. Invading
cells on the lower surface of the membrane were ﬁxed with methanol
and stained with 1% Toluidine blue (Fluka) in 1% borax. For quantiﬁca-
tion, the membranes were mounted to glass slides, and the cells from 5
randommicroscopic ﬁelds (×200 magniﬁcation) were counted. Assays
were performed in duplicate, and migration was expressed in terms of
cells/ﬁeld.
2.4. Young's modulus measurements.
AFM measurements were performed using a commercial Solver Bio
atomic force microscope (NT-MDT, Russia), combined with an inverted
optical microscope (Olympus, Japan) as described previously [47]. Cells,
subjected to AFMmeasurements, were non-conﬂuent (about 60%), and
well attached to the Petri dish surface. Typically, 3–5 force curves were
taken at a 2 μm/s rate from each of the studied cells near its center using
tipless AFM probes CSG11 (NT-MDT, Russia) modiﬁed with a 9 μm
diameter polystyrene bead. Hertz's contact model was applied for pro-
cessing of the ﬁrst 500 nmof indentations to calculate apparent Young's
modulus (E). Experiments were conducted during a 30–40 min period,
at 37 °C, after replacing the growth medium with the DMEM HAM/F12
mediumwith 15mMHEPES (Sigma, United States). Three independent
experiments were conducted for each cell line before and after treat-
ment, with 10–25 cells analyzed in each experiment.
Viscoelastic behavior of cells was characterized by applying low-
amplitude (10–15 nm) sinusoidal perturbations with a 0.3–230 Hz
frequency (in a random order) to scanner Z-electrodes, when the
cantilever was at a ≈500 nm indentation. An E*(f) was computed
with correction for the tip-cell contact geometry (the ﬁrst term of the
Taylor expansion of the Hertz model was used) and for the hydrody-
namic viscous drag [51]. At least 10 cells of each cell linewere analyzed.
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A non-parametric Mann–Whitney U test was used to determine the
statistically signiﬁcant differences between the groups. Analysis was
performed using the Statistica software, version 8.0 (StatSoft, USA).
Since the Young's modulus values were distributed log-normally, they
were described as geometric mean */ multiplicative standard deviation
and in standard form as arithmetic mean ± SD. N – total number of
cells measured in all experiments. Box-and-whisker plots are shown
for log-normally-distributed data, and the percentiles are 10%, 25%,
50%, 75% and 90%.
3. Results
3.1. Morphology, cytoskeleton features, invasiveness and mechanical
properties of normal and cancer cells
In confocal microscopy experiments the difference in cytoskeleton
structure and morphology of Vero and DU145 cell lines was revealed.
Vero cells exhibited an epithelial-likemorphology, the F-actinwas orga-
nized into prominent contractile bundles (stress ﬁbers), located
predominantly at the basal part of the cell, just above the substrate
(Fig. 1a). DU145 cells had a polygonal or elongated shape with a signif-
icant number of small ﬁlopodia, and F-actin cables and bundles were
thinner than in Vero cells. Thickness of F-actin bundles evaluated from
several (5–7) confocal images was 0.5 ± 0.1 for Vero and 0.3 ±
0.1 μm for DU145 cells, but this is a rather qualitative evaluation, since
these values are close to the resolution limit of the confocal microscope.
Although it might be just the inherent characteristics of these cell lines,Fig. 1.Morphology, cytoskeleton features, invasiveness and mechanical properties of normal (
images, scale bar 20 μm. Cells were stained with Alexa Fluor® 546-conjugated phalloidin and D
corresponding images. Vero cells have thicker actin bundles than DU145 cells (wider peaks on
studied cells.the signiﬁcant reduction in the thickness of F-actin cables and bundles
was previously reported for different types of cancer cells [34,35,45,
46,52].
To study the invasiveness of normal and cancer cells, we used the 3D
transwell Matrigel invasion assay (Fig. 1b). As expected, prostate cancer
cell line DU145 shows signiﬁcant invasion abilities in comparison to
Vero cells. Moderate invasiveness of DU145 cells was observed previ-
ously and it reﬂects the metastatic potential of these cells [53].
The Young's modulus measured by force spectroscopy for Vero cells
was 1300± 900 (geometric mean 1000*/1.9,N=324) Pa (Fig. 1c). The
Young'smoduli of DU145 cellswere signiﬁcantly (~60%, p b 0.01) lower,
with values of 600 ± 400 (450*/2.0, N = 328) Pa, apparently due to a
weaker cytoskeleton structure of DU145 cells. All of the studied cell
lines demonstrated log-normal distribution of Young's modulus values
with close multiplicative standard deviation values [47].
3.2. Viscoelastic properties of Vero and DU145 cells
The components of the complex Young's modulus (E*) measured at
different frequencies for control Vero and cancer DU145 cells are shown
in Fig. 2. At low frequencies (below 10 Hz) E′ was at least three times
higher than E″ for both cell lines, so they demonstrated solid-like behav-
ior (loss tangent ~0.3). The frequency dependence of E* of Vero and
DU145 cells clearly exhibited a power–law behavior. Both average and
single cell E*(f) data were ﬁtted well with the power–law structural
damping model [51,54].
E fð Þ ¼ E0 1þ iηð Þ ff 0
 α
þ i f μ; ð1ÞVero) and prostate cancer (DU145) cells growing in vitro. (a) Actin cytoskeleton, confocal
API to visualize F-actin and nuclei. Insets – ﬂuorescence intensities across the lines on the
line graphs). (b) Invasion of studied cells through the Matrigel. (c) Young's moduli of the
Fig. 2.Viscoelastic properties of Vero andDU145 cells. A plot of the average Е′ and E″ of Vero andDU145 cells as a function of frequency. Solid lines represent the resultant ﬁt by the power–
law structural damping model, Eq. (1). Error bars represent the standard deviation.
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cient of the model, and f0 is a scale factor for frequency (1 Hz in this
work). DU145 had lower values of the scale factor for storage and loss
moduli E0 (600 ± 200 vs. 1000 ± 300 Pa in control cells) and higher
values of the power–law exponent α (0.18 ± 0.07 versus 0.14 ±
0.04), while values of Newtonian viscosity μ were close in both cell
types (5 ± 2 and 7 ± 4 Pa s for DU145 and Vero cells, respectively).
Such results correspond well with the data obtained from quasi-static
experiments (force curves). When applying low indentation speeds
during force spectroscopy experiments, an elastic response is mostly
obtained, and the measured quasi-static Young's modulus for cancer
cells is lower than for normal cells due to the difference in E0. But at
higher indentation speeds an observable decrease in effective Young's
modulus of cancer cells can be diminished due to differences in the
power–law exponent.3.3. Inﬂuence of actin cytoskeleton reorganization on the mechanical
properties of Vero and DU145 cells
As a positive control, we used Cytochalasin D (CytD), which causes
the non-speciﬁc inhibition of actin polymerization. CytD is a cell-
permeable fungal toxin that affects intracellular actin cytoskeletal
dynamics via multiple mechanisms [55]. After several (10–15) min of
CytD treatment (4 μM), almost complete disassembly of actin ﬁlaments
and a signiﬁcant decrease in Young's moduli (80% for DU145, 90% for
Vero) of both cell lineswere observed (Fig. 3a). Young'smoduli of treat-
ed cells measured after 15 min of incubation with CytD were around
80–100 Pa. Residual F-actin in cells formed foci and small punctate
structures. The integral ﬂuorescent signal of the labeled F-actin
(Fig. 3b) reduced signiﬁcantly for both cell lines, 65% for Vero and 40%
for DU145 (p b 0.01). We did not observe any effects of DMSO (a
solvent for actin polymerization inhibitors) addition to the medium on
cell mechanical properties and the actin cytoskeleton structure at the
working concentrations (≈0.5% v/v) and times used (15 min–2 h,
data not shown).
To study the differences in actin cytoskeleton structure upon formin
inactivation, the cells were incubated with a small molecule inhibitor of
formin-mediated actin assembly, SMIFH2 [49], at a concentration of
20 μM for 2 h. After treatment with SMIFH2, the number of thick actin
ﬁlaments (Fig. 3a) and integral ﬂuorescent signal of labeled F-actin
in the Vero cells decreased (Fig. 3b). The remaining ﬁlaments were
generally located in the basal part of the cells. The Young's moduli of
Vero cells were decreased by ~90% (p b 0.01), which is similar to results
from the CytD treatment (Fig. 3c). No signiﬁcant inﬂuence of formin
inhibitor SMIFH2 on the cytoskeleton morphology has been found in
the prostate cancer cell line DU145 (Fig. 3a). The integral ﬂuorescentsignal of labeled F-actin (Fig. 3b) and Young'smodulus (Fig. 3c) reduced
slightly (~20%, p b 0.01).
The Arp2/3 complex-dependent pathway of actin nucleation was
inhibited using a small molecule inhibitor, CK-666. It is known that
the Arp2/3-mediated actin assembly takes place on the leading edge
of moving cells [56].We did not observe any effects of Arp2/3 inhibition
with CK-666 (100 μM, 2 h) on the actin cytoskeleton structure (Fig. 3a,
B) and the mechanical properties of cells (Fig. 3c). As shown previously
for epithelial cells [57], CK-666mostly affects the quantity and structure
of lamellipodia, thus impairing cell motility.
Inhibition of ROCK with Y-27632 (50 μM, 1 h) led to a signiﬁcant
decrease in Young's moduli of both cell lines (Fig. 3c), which was
more pronounced for Vero cells (~70% versus ~30% for DU145). ROCK
regulates the formation of contractile actin stress ﬁbers [25]. Most of
thick and long actin bundles in Y-27632-treated cells disappeared
(Fig. 3a), although a reduction in the integral ﬂuorescent signal of la-
beled F-actin was observed only for DU145 cells (~50%, p b 0.01). Cell
softening after ROCK inhibition could also be associated with decrease
in the cortical tension [58,59].
Surprisingly, we observed a different response of Vero and DU145
cells to trypsinization (Fig. 3c). After 20 min of trypsinization, cells
were rounded and only slightly attached to the surface. It should be
noted, that the application of the simple Hertz model in such measure-
ments should lead to relatively good estimations of the cell's Young's
modulus, since a distinct contact area with the substrate exists [60].
Detachment leads to the destruction of focal adhesions, intracellular con-
tacts and associated stress ﬁbers. Since contractile stress ﬁbers play a
major role in the determination of cell stiffness [45,46], their disassembly
should lead to cell softening. We were able to observe such an effect for
Vero cells (reduction ~70%, p b 0.01). In contrast, the cancer cells demon-
strated a signiﬁcant increase in Young'smoduli (~50%, p b 0.01). On con-
focal images (medium section) the cortical actin layer seemed thicker in
DU145 cells (~1 μmversus ~0.7 μm in Vero cells), although this is only a
qualitative evaluation due to the limited resolution of the confocal
microscope. The integral ﬂuorescent signal of labeled F-actin was not
calculated for these cells because of the large cell height and complicated
F-actin distribution in them. The results of all treatments are summarized
in Table 1. The difference between daily control experiments may be
caused by subtle uncontrolled experimental factors, like the difference
in medium or FBS composition between batches, conﬂuency level (be-
tween 50% and 70% in this work), quality of glass substrate, passage
number and others.
4. Discussion
Mechanical properties of cancer cells play an important role in the
metastatic process, when the activemigration of cells to the neighboring
Fig. 3. Impact of actin cytoskeleton reorganizations onmechanical properties of Vero and DU145 cells. (a) Cytoskeleton reorganizations in Vero and DU145 cells after different treatments
(CytD 4 μM 15 min, SMIFH2 20 μM 2 h, CK-666 100 μM 2 h, Y-27632 50 μM 1 h, trypsinization), confocal images, scale bar 10 μm. (b) F-actin level in the studied cells before and after
treatments expressed as arbitrary ﬂuorescence intensity. (c) Young's moduli calculated for Vero and DU145 cells before and after treatments.
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in the structure of the cytoskeleton [61]. It is well known that epithelial
cells may undergo a so-called epithelial–mesenchymal transition
during carcinogenesis [62], at which point intercellular contacts break,
cells become more elongated, and can move alone, along with amesenchymal–amoeboid transition, which further increases cancer
cellmigration abilities [63]. These transitions greatly improve the ability
of an individual cell to migrate and invade into the neighboring tissues.
Pathways that lead to restructuring of the actin cytoskeleton in cancer
cells remain largely unknown.
Table 1
Young'smoduli calculated for the cell lines (in Pa). Data are presented as geometricmeans
*/ multiplicative standard deviation. Data for control cells obtained in the same day are
provided in brackets. The percent change from the control values is shown.
Cell line CytD SMIFH2 CK-666 Y-27632 Trypsinization
Vero 80*/1.7 130*/2.5 1200*/1.8 300*/1.6 240*/2.2
(710*/1.7) (1300*/1.8) (1300*/1.7) (1100*/1.8) (900*/2.2)
~90% ~90% ~8% ~70% ~70%
p b 0.001 p b 0.001 p= 0.44 p b 0.01 p b 0.001
Du145 70*/1.6 340*/2.2 720*/1.8 250*/1.6 700*/2.3
(320*/2.1) (440*/1.8) (760*/1.7) (350*/1.7) (480*/1.8)
~80% ~23% ~5% ~30% ~50%
p b 0.001 p b 0.001 p= 0.23 p b 0.01 p b 0.001
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and invasion ability of normal and cancer cells. We compared the Vero
kidney epithelial cell line with prostate cancer epithelial cell line
DU145 established from the brain metastases [48]. The DU145 cell line
possesses the medium invasive capability in accordance with previous
research [64] and maintains tumorigenic properties [65], while Vero
cells normally do not [66]. It should be noted that these cell lines have
different tissue origin (kidney and prostate), so we cannot exclude the
tissue-speciﬁc nature of effects observed in this work. However, as
shown here, all common properties, including invasion abilities, cyto-
skeleton structure and Young's modulus, which distinguish normal
and cancer cells, may be observed in this cell system. Although the
genetic and molecular origin of malignancy is multifaceted, changes in
the mentioned parameters during the progression of disease are com-
mon to many forms of cancer [33–35,45,46,52].
Actin polymerization and the formation of an entangled cortical
network facilitate cellmigration [67]. These processes lead to the chang-
ing stiffness of migrating cells, which can be characterized by the
Young's modulus value. Measurement of the Young's modulus using
AFM has been suggested as a powerful method to study processes that
involve cytoskeleton reorganization [29,31,32,37]. In the current work,
we used AFM cantilevers modiﬁed with microspheres in order to
accurately control the probe geometry and to rapidly obtain Young's
modulus values, averaged over a signiﬁcant (~1 μm2) contact area, as
described earlier [47]. Representative force curves, which were obtain-
ed on both cell lines, are shown in Fig. S1, accompanied with the results
of the Hertz model ﬁtting. Although other models for extraction of me-
chanical properties from force curves are emerging [27,28], applicability
of Hertzian contact mechanics was shown in the majority of work on
different cell samples [26,35,45,68]. Here, a good agreement between
the Hertz model ﬁts and experimental data was also observed for both
cell lines before and after treatments (adjusted R2≈ 0.95–0.99).
The obtained Young's moduli for normal Vero cells were typically
1.3 ± 0.9 kPa, which is consistent with the previous results for non-
malignant cells [68], but higher than the values reported previously by
our group [47]. This is apparently due to the usage of culture medium
instead of PBS and a higher indentation speed (2 versus 1 μm/s) in the
current AFM experiments. DU145 cancer cells exhibited signiﬁcantly
lower Young's moduli (~40% of normal value). The E values obtained
for DU145 cells differ from those obtained previously by other scientiﬁc
groups [32], who used sharp cantilevers for force spectroscopy. Our
results were systematically lower, probably due to the application of
cantilevers with attached microspheres [69] or differences in passage
numbers. The basic difference in stiffness between normal and cancer
cells remains the same.
The viscoelastic behavior of Vero and DU145 cells was consistent
with the soft glassy rheology (SGR) model [54]. Accordingly, E*(f) data
ﬁtted well with the power–law structural damping model, which is
considered to be governed by SGR. As expected from the model, softer
DU145 cells had a lower value of power–law exponent α than Vero
cells. Similar results were obtained in the work [27], where an inverse
correlation between G0 (storage modulus scaling factor) and α wasfound for human breast benign and malignant cell lines. Since storage
modulus is much higher than loss modulus at low frequencies, quasi-
static force spectroscopy experiments at low indentation speeds pro-
vide a quite close estimation of cell Young's modulus. Such experiments
were conducted with Vero and DU145 cells after treatment with
different agents causing actin cytoskeleton reorganization.
Total inhibition of actin polymerization by CytD led to a rapid
(b15 min) and signiﬁcant reduction in Young's moduli of both Vero
and DU145 cells (Fig. 3b). CytD at the concentration used (4 μM) not
only binds to the barbed ends of actin ﬁlaments, thus inhibiting both
the polymerization and depolymerization of actin subunits, but also
binds to the actin monomers [55]. Although themechanism of CytD ac-
tion is still not fully understood, it is probably linked to both interactions
with ﬁlament barbed ends and capping proteins, actin monomers and
monomer binding proteins. Except for a decrease in the integral intensi-
ty of ﬂuorescently labeled F-actin, CytD treatment modiﬁes cytoskele-
ton organization from an isotropic network to focal accumulations
(Fig. 3a). It is not surprising that such alterations severely affect the
mechanical properties of a cell; this was also shown in previous works
with Cytochalasins D or B [46,70,71]. Such a result also proves the
major contribution of the actin cytoskeleton in determiningmechanical
properties of the studied cells.
The two main actin nucleation pathways in the cell are formin-
dependent and Arp2/3-dependent. After treatment with formin inhibi-
tor SMIFH2 [49], the Young's moduli of normal Vero cells decreased by
70% (Fig. 3b). The opposite effect – an increase in stiffness –was previ-
ously shown for ﬁbroblasts after transfection with a constitutively
active mutant of formin Dia1, which is in agreement with our data
[72]. The actin polymerization inhibitor SMIFH2 acts by binding to the
highly conserved FH2 domain and breaking its interaction with F-actin
using an unknown mechanism [49]. These interactions are so strong
and speciﬁc that SMIFH2 may displace formin from the barbed end of
the pre-formed F-actin ﬁlaments in the absence of proﬁlin. Consistently,
the width and number of actin bundles were reduced in Vero cells
(Fig. 3a). The overall intensity of labeled F-actin in treated cells was
~40% lower (Fig. 3b).
Earlier it has been demonstrated that carcinoma cell line A549 was
more resistant to SMIFH2 treatment than benign cells in terms of viabil-
ity [49]. Here we showed that treatment of DU145 prostate cancer cells
with SMIFH2 was also ineffective. Unlike Vero, DU145 cell treatment
with SMIFH2 poorly affects the cytoskeleton, since there were no pro-
nounced actin bundles initially, and causes only a slight reduction in
stiffness (~20%). This observed softening might be partially attributed
to cortex weakening. Indeed, formin-dependent actin nucleation was
shown to be important for cell cortex formation [73].
There is an increasing amount of evidence that shows that genes
encoding formins are often lost in prostate, breast, hematopoietic
and colorectal cancer cells [74–76]. On the other hand, an elevation of
formin gene (FMNL2) expression in metastatic cancer cell lines [15]
has been reported. Our results suggest that, in the DU145 prostate
cancer cell line, formin is actually less active and may not be associated
with F-actin cables. This is in agreement with recent ﬁndings of mDia1
and mDia2, associated with cortical actin pools in epithelial cancer
cells [77].
Inhibition of Arp2/3-dependent polymerization by the small mole-
cule CK-666 poorly affected the cytoskeleton structure and mechanical
properties of the studied cell lines. Recently reported, the crystal struc-
ture of the CK-666 bound to the Arp2/3 complex revealed that CK-666
binds between the Arp2 and Arp3 subunits to stabilize the inactive
open conformation of the complex [50]. As shownpreviously for epithe-
lial cells [57], treatmentwith CK-666 at high concentrations (100 μm, as
used here, and higher) caused the formation of clustered and bundled
actin ﬁbers. We did not observe such alterations in the current work.
Probably, the cells studied here were more resistant to Arp2/3 in-
hibition, like some other cell types [78]. It is worth mentioning that
CK-666 mostly affects the quantity and structure of lamellipodia, thus
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mechanical properties, and therefore suppose that Arp2/3-inhibition
has a poor effect on them. As recently shown, the Arp2/3 complex
is also important for the generation of cortical actin [79]. However,
apparently, inhibition of the Arp2/3 complex alone is not enough for
the cortex weakening.
Rho kinase regulates intracellular mechanics in a different way
compared to actin nucleators. While nucleators increase the total level
of polymerized actin in the cell, the activation of ROCK causes an in-
crease in actomyosin contractility. Enhanced actomyosin contractility
manifested, in particular in stronger stress ﬁbers and focal adhesions,
a higher cortical tension. ROCK induces these effects, mainly by phos-
phorylating myosin light chains and the assembly of myosin II motors
[25]. Contractility affects measured Young's modulus of cells. In general,
cells with a higher contractility level should have higher Young'smoduli
[80]. As previously shown, the inhibition of ROCK with Y-27632 or my-
osin II with blebbistatin led to a decrease in cell stiffness [81–83]. Here,
we observed the same effect, which was more pronounced in normal
Vero cells (~70% versus ~30% in DU145) and, apparently, associated
with the disassembly of stress ﬁbers. A decrease in cortical tension is
also possible for both cell lines.
Actin cytoskeleton reorganization, caused by cell detachment from
the substrate by trypsinization, had an opposite impact on Vero and
DU145 cells. Vero cells demonstrated a signiﬁcant reduction in Young's
modulus, apparently, as in previous case, associated with the disassem-
bly of stress ﬁbers. At the same time, the Young's modulus of DU145
cells increased (Fig. 3b). Initially DU145 had a less developed stress
ﬁber system than Vero cells; therefore, during AFMmeasurements, we
expected the cortical actin to mainly contribute to DU145 cell mechan-
ical properties. The actin cytoskeleton structure depends on signals
caught by receptors, which facilitate cell–cell (e.g. cadherins) and cell–
substrate contact formation (e.g. integrins in focal adhesion structures).
These receptors undergo partial proteolytic degradation at the extracel-
lular domains by trypsinization and, as a consequence, the actin cyto-
skeleton rearranges, due to the disruption of these signaling cascades.
These rearrangements in the actin cytoskeleton of DU145 cells may
lead to reinforcement of the cortical actin, increasing cortical tension,
and thus in higher stiffness values. Cortical tension is generated by acto-
myosin contractility, which is controlled by small GTPase RhoA, ROCK
and myosin light chain kinase MLCK [84]. Rac1, another small GTPase,
regulates Arp2/3-dependent actin polymerization in lamellipodia of
adherent cells. As demonstrated previously, cortical tension is higher
in cells with higher RhoA-ROCK than Rac1 activity, in other words,
when contractility dominates over actin polymerization [85]. Elevated
RhoA, ROCK and MLCK expressions have been detected in several
types of tumors and cancer cell lines (listed in [25]), which may lead
to a rapid switch to activation of RhoA in cancer, but not in normal
cells detached from the substrate.
The cortical actin plays a signiﬁcant role in cancer cell migration and
mechanics. Amoeboid-type movement of cancer cells is predominantly
generated by cortical F-actin rearrangements and cortical actomyosin
contractility [63]. Amoeboid cells are naturally representing at least
the part of the population within DU145 and other aggressive prostate
cancer cell lines [75]. Another aspect of cortical mechanics may be con-
nected with the viability of cells in the circulation. During metastasis,
cancer cells enter the circulation in order to gain access to distant
tissues; ﬂuid shear stress arises from hemodynamic shear forces, affect-
ing cells in the vessels. Compared to non-transformed cells, cancer cells
are more resistant to ﬂuid shear stress [59], which may be a conse-
quence of altered actin cytoskeleton regulation.
The distinct impact of targeted actin cytoskeleton reorganization on
normal and malignant cells provides new information about malignant
changes and can serve as an additional diagnosticmarker. Future exper-
iments with optimal control cell lines, cells from patients and complex
impacts of inhibitors or activators should clarify the molecular mecha-
nisms of malignancy.5. Conclusions
The actin cytoskeleton is rearranged in cancer cells, promoting
invasion and the formation of metastases. Here, we demonstrate that
large actin bundles are absent in adherent prostate cancer DU145
cells, making them more compliant, compared to normal Vero cells.
The frequency dependences of the complex Young's modulus were
ﬁtted well with the power–law structural damping model for both cell
lines; DU145 cells demonstrated higher values of the power–law expo-
nent. Cancer cell treatment with speciﬁc actin nucleator inhibitors
(SMIFH2 and CK666) did not signiﬁcantly affect their stiffness, while
the inhibition of Rho kinase decreased it. On the other hand, detach-
ment of cancer cells from the surface by trypsinization increased their
stiffness. The data reported here might evidence cortical actin playing
a signiﬁcant role in cancer cell mechanics and migration.
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